Bipolar Disorder in Pediatric and Adolescents (depressive episode)

January 06, 2017

Location: Hartford Hospital's Institute of Living

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 10-17 years of age for a clinical trial testing the safety and efficacy of Lurasidone treatment study in pediatric and adolescent depression associated with Bipolar I Disorder. All subjects who complete the 6-week study are eligible for a 104 week open-label flexible-dose trial of Lurasidone.

For more information about this trial, please contact:

Dr. Salma Malik
Phone: 860.545.7502